Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1.24M
-
Shares change
-
-202K
-
Total reported value, excl. options
-
$2.12M
-
Value change
-
-$537K
-
Number of buys
-
10
-
Number of sells
-
-9
-
Price
-
$1.71
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q1 2025
27 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q1 2025.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.24M shares
.
Largest 10 shareholders include Invenomic Capital Management LP (550K shares), GEODE CAPITAL MANAGEMENT, LLC (172K shares), TORONTO DOMINION BANK (130K shares), VANGUARD GROUP INC (128K shares), RAYMOND JAMES FINANCIAL INC (61.3K shares), STATE STREET CORP (39.3K shares), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (31K shares), Byrne Asset Management LLC (28.9K shares), BlackRock, Inc. (27.4K shares), and HighTower Advisors, LLC (21K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.